The global market for biosimilars has faced substantial turbulence throughout the pandemic. Viral spread and lockdown measures have led to unforeseen challenges in supply chain operations, creating production delays and influencing delivery mechanisms worldwide. Concurrently, the focus of the global healthcare system has been diverted to managing COVID-19's fallout, causing...
Discover more insightsIn the global pharmaceutical landscape, biosimulation holds a prominent role due to its application in drug discovery. Utilized as a scientific approach to predict responses to drugs and disease progress within human cells, it facilitates decision-making processes and accelerates product development trajectories. Enhanced predictability reduces the time and cost associated...
Discover more insightsThe COVID-19 pandemic has undeniably influenced various industries, and the biosimilars market is no exception. Faced with unprecedented challenges, the market has shown resilience. Despite initial disruption due to lockdown restrictions affecting production and distribution, quick rebound has been noted due to increased cost-consciousness and demand for affordable healthcare in...
Discover more insightsThe COVID-19 pandemic significantly disrupted healthcare systems worldwide, significantly impacting treatment regimes for a myriad of diseases, including those necessitating the use of immunosuppressants. A shift to emergency response mode and the reframing of resources toward COVID-19 treatment protocol led to decreased accessibility and availability of these essential drugs. As...
Discover more insightsThe sharp global focus on COVID-19 has accelerated advancements in vaccines and therapeutics to an unprecedented speed. Several vaccines, such as those developed by Pfizer-BioNTech, Moderna, and AstraZeneca-Oxford have gained emergency use authorization worldwide after demonstrating significant efficacy in phase III trials. Simultaneously, therapeutics such as monoclonal antibodies and antivirals...
Discover more insightsLooking at the current dynamics, development strategies in the relevant field have been experiencing innovation and growth. Researchers and companies are increasingly focusing on state-of-the-art methods to improve production and purification processes. Additionally, there is a gradually increasing emphasis on integrating artificial intelligence in the development processes to increase the...
Discover more insightsIn the dynamic world of pharmaceuticals, an important subset of the industry is gaining prominence. This subset consists of biobetters', which are modifications of existing biologics or biotherapeutic drugs intended to improve their effectiveness, safety, or method of administration. Biobetters are expected to increasingly become a key focus in the...
Discover more insightsAs tertiary products emerging out of medical biotechnology, biosimilars face a rigorous and meticulous regulatory procedure. With their complex molecular structure, the approval process extends beyond a simple scrutiny of bioequivalence, necessitating intensive comparative studies on safety, quality, and efficacy against the innovator product. The ensuing competitive market tension drives...
Discover more insightsElectroceuticals represent a novel subset within the broader field of bioelectric medicine, employing electrical signals to modulate biological processes for therapeutic effects. By intercepting or emulating the native bioelectrical conversations between cells and tissues, scientists can potentially vie and manipulate health circumstances. More straightforward than molecular intervention, electroceuticals aim to...
Discover more insightsProgress in immunotherapy has led to the increasing prominence of interleukin therapies, which work by manipulating the body's immune response. Cellular immunotherapies using interleukins, such as IL-2, have demonstrated notable success in treating a range of illnesses, in particular cancers and autoimmune diseases. Investment in R&D in this area appears...
Discover more insightsThe Biosimilar market, a sub-segment of the broader pharmaceutical industry, is currently gaining momentum due to increased recognition and acceptance. The market's growth is primarily fueled by patent expirations of notable biologics, resulting in the surge of more affordable biosimilar options. Cost-effectiveness, coupled with the assurance of quality and safety...
Discover more insightsThe increasing prevalence of Phenylketonuria (PKU) - a genetic disorder characterized by an inability to metabolize phenylalanine - is fostering a significant demand for effective treatments. Simultaneously, advances in genetic technologies are creating new potential avenues for innovation within this market. The development of genetically tailored treatments is becoming more...
Discover more insightsAs biologic medicines near patent expiration, biosimilars - cheaper, highly similar versions - have become a topic of interest for many investors. The global market is projected to reach $35.7 billion by 2025, spurred by increasing healthcare cost pressures and an aging population with escalating chronic disease prevalence. While North...
Discover more insightsThe biosimilar sector, characterised by pharmaceuticals which are nearly identical copies of original brand medications, is experiencing an increasing growth pace. This uptick can be attributed to patent expiry of multiple branded biologics, creating a window for their biosimilar counterparts. Additionally, an influx of strategic and manufacturing partnerships within the...
Discover more insightsIn the realm of biopharmaceuticals, notable strides are being made in the development and application of biosimilar lymphocyte modulators. These groundbreaking advancements are implicitly restructuring medical protocols as they offer effective therapeutic alternatives to previously explored avenues. Focused on re-engineering the body's responses to disease, these biosimilars emulate the functions...
Discover more insightsThe field of immunotherapy, an approach to medical treatment that leverages the body's immune system to fight diseases, has been undergoing rapid advances. Key drivers of this progress include sophisticated biotechnologies which support enhanced precision and personalized therapy, and groundbreaking clinical research leading to novel treatments in oncology, allergies, and...
Discover more insightsIncorporation of technology with biology has observed a major uptick, introducing the market to the phenomenon of biosimulation. A robust computational technique, biosimulation aids in the simulation of biological processes, thereby refining function and performance of pharmaceutical research. Unprecedented advancements in drug development, growing acceptance of quantitative systems pharmacology (QSP)...
Discover more insightsShifting global health paradigms, largely ushered in by scientific advances and the onset of new diseases, have firmly placed substantial demand for efficient antibody tests. A method for discovering disease presence and monitoring patient progress, these tests are integral to clinical practice. As more conditions are explored and understood, growth...
Discover more insightsBiorationals, a derived segment of the overall biopesticides market, is shaping agribusiness with its potential for growth. This rise can be ascribed to market drivers such as rising global food demand, growing awareness about environmental sustainability, and stringent regulatory pressure on chemical pesticides. These agricultural substances, inherently less toxic than...
Discover more insightsAntibody therapies are poised for exponential growth in the biopharmaceutical sector, shaped by various drivers. Key influences include advances in technology, which enable the development of novel and targeted treatments. Additionally, as demographic shifts contribute to a rising incidence of chronic diseases, there's growing demand for personalized and effective therapeutics....
Discover more insightsEvolving regulatory landscapes and heightened awareness about the hazards associated with Per- and polyfluoroalkyl substances (PFAS) have led to increased pressure on the water industry to provide safer, more sustainable solutions. Escalating demand for clean, potable water amidst rapidly growing populations, has necessitated the development of PFAS treatment technologies that...
Discover more insightsEmerging research identifies viral therapy, particularly bacteriophages, as a potential breakthrough in combating antibiotic-resistant bacteria. These viruses have the explicit ability to infiltrate bacterial cells, disrupt their reproductive processes, and cause them to self-destruct. Their adaptability and specificity make them a potent tool in countering resistant strains of bacteria that...
Discover more insightsScientific and technical progress has opened up new horizons for the treatment of amino acid metabolism disorders. Present advancements range from novel enzymatic therapies to advanced genetic modification techniques. Gene editing technologies, such as CRISPR-Cas9, are now being applied to re-program defective metabolism routes. Additionally, nanotechnology-based drug delivery systems hold...
Discover more insightsThe global healthcare market, encompassing both pharmaceuticals and medical devices, is driven by several key factors. Aging populations in developed nations and increased health consciousness worldwide fuel a constant demand. Additionally, robust innovation - from novel drug development to advancing medical technologies - propels this sector. However, high research and...
Discover more insightsThe antibodies contract manufacturing sector is emerging as a highly specialized aspect of pharmaceutical manufacturing. It presents a combination of scientific prowess and industrial engineering, driven by the increasing demand for antibodies in various high-growth areas of healthcare, including diagnostics and therapeutics. In essence, this sector represents a delicately balance...
Discover more insightsThe biostimulants market experiences considerable expansion due to a convergence of factors. Stricter environmental regulations encourage the development and use of eco-friendly products, which positions biostimulants as an attractive solution. The drive for sustainable agriculture also attributes to this growth. The increasing global population necessitates improved crop yield and quality,...
Discover more insightsThe Clostridium vaccine sector within the veterinary medicine market is both dynamic and evolving. Market demand is growing due to increased pet adoption, rising veterinary healthcare expenditure, growing awareness about animal health, and expanding livestock sector worldwide. In particular, Clostridium vaccines, which are essential for preventing clostridial diseases in animals,...
Discover more insightsAt present, the ethylene glycol market is characterized by increased consumption in sectors such as polyester fibers, polyethylene terephthalate (PET), and antifreeze applications. Additionally, significant growth in demand from emerging economies in Asia-Pacific, particularly China and India, is underpinning market expansion. Challenges include fluctuations in raw material costs and environmental...
Discover more insightsThe Glycol market has witnessed notable fluctuations in recent years, primarily driven by the diversified uses of glycols in various industries. Most significantly, the demand for Polyethylene Glycol (PEG) in pharmaceutical applications has soared owing to its properties such as solvency, hygroscopicity, and low volatility. Furthermore, the escalating needs in...
Discover more insightsThe field of neurological restoration is advancing rapidly, propelled by significant technological advancements and increasing focus on research and development activities. The proliferation of novel surgical techniques, neurotransplantation methods, and biomaterial-based nerve conduits have been instrumental in shaping up the sector's landscape. Moreover, cell therapy, primarily stem cell therapy, for...
Discover more insights